• Explore /
  • Poster
  • / Phase 1/2 evaluation of revumenib in patients with advanced colorectal cancer and other solid tumors.

Phase 1/2 evaluation of revumenib in patients with advanced colorectal cancer and other solid tumors.

Abstract Poster

Authors

null

Aparna Raj Parikh

Massachusetts General Hospital Cancer Center, Boston, MA

Aparna Raj Parikh , Vedran Radojcic , Myles Clancy , Susan Brouwer , Shaliny Kushwaha , Yifan Huang , Nashat Gabrail

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05731947

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr TPS227)

DOI

10.1200/JCO.2024.42.3_suppl.TPS227

Abstract #

TPS227

Poster Bd #

N15

Abstract Disclosures

Similar Posters

First Author: Paul Eliezer Oberstein

First Author: Angela Damato

First Author: T.R. Jeffry Evans

First Author: Sarah Patricia Blagden